1-5 of 5
Heiko Konig, MDPhD
Close
Sort by
Journal Articles

Impact of Leukapheresis and Time to Chemotherapy on Outcomes of Newly Diagnosed Patients (pts) with Acute Myeloid Leukemia (AML) Presenting with Hyperleukocytosis: An Analysis from a Large International Patient Cohort

Maximilian Stahl, MD, Wei Wei, MD PhD, Pau Montesinos, MD PhD, Etienne Lengline, MD, Rory M Shallis, MD, Judith Neukirchen, MD, Vijaya R. Bhatt, MD, Mikkael A. Sekeres, MD MS, Amir T. Fathi, MD, Heiko Konig, MDPhD, Selina Luger, MD, Irum Khan, MBBS, Gail J. Roboz, MD, Thomas Cluzeau, MD PhD, David Martínez-Cuadron, MD, Emmanuel Raffoux, MD, Ulrich Germing, MD, Jayadev Manikkam Umakanthan, MBBS, Sudipto Mukherjee, MD PhD MPH, Andrew M. Brunner, MD, Adam M. Miller, BS, MD, Christine M. McMahon, MD, Ellen K. Ritchie, MD, Rebeca Rodríguez-Veiga, MD, Raphael Itzykson, MD PhD, Blanca Boluda, MD, Florence Rabian, MD, Mar Tormo, MD, Evelyn Gloria Acuna Cruz, MD, Emma Rabinovich, MD, Brendan Yoo, Nikolai A. Podoltsev, MD PhD, Steven D. Gore, MD, Amer M. Zeidan, MBBS, MHS
Journal: Blood
Blood (2018) 132 (Supplement 1): 1428.
https://doi.org/10.1182/blood-2018-99-112495
Published: 2018
Journal Articles

A Multi-Institution Comparison of Mitoxantrone, Etoposide and Cytarabine (MEC) Vs High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Sonia Christian, MD, Pritesh Patel, MD, Vaibhav Agrawal, MD MBA, Shawn Griffin, PharmD, Kirk Cahill, MD, Irum Khan, MBBS, Karen Sweiss, PharmD, Ardaman Shergill, MD, Gregory Sampang Calip, PharmD,MPH,PhD, Wendy Stock, MD, Olatoyosi Odenike, MD, Heiko Konig, MDPhD, John G. Quigley
Journal: Blood
Blood (2018) 132 (Supplement 1): 1397.
https://doi.org/10.1182/blood-2018-99-111389
Published: 2018
Journal Articles

Inhibition of Carbonic Anhydrase-IX As a Novel Strategy to Overcome Hypoxia Mediated Drug Resistance in FLT3/ITD Mutated Acute Myeloid Leukemia

Fangli Chen, MD PhD, Adriana Rogozea, George Sandusky, DVM, PhD, Mircea Ivan, MD PhD, Heiko Konig, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2521.
https://doi.org/10.1182/blood.V130.Suppl_1.2521.2521
Published: 2017
Journal Articles

Minimal Intensity Fludarabine/Cyclophosphamide Versus Myeloablative Thiotepa/Cyclophosphamide Followed By Allogeneic Hematopoetic Stem Cell Transplantation (HSCT) for the Treatment of Acute Myeloid Leukemia (AML)— a Retrospective Single Institution Experience

Nabin Khanal, MBBS, Brian E Johnson, MD, H. Scott Boswell, MD, Heiko Konig, MDPhD, Susan M Perkins, PhD, Robert P. Nelson, Jr., MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5471.
https://doi.org/10.1182/blood.V130.Suppl_1.5471.5471
Published: 2017
Journal Articles

The Combination of the Novel Syk Inhibitor TAK659 with Decitabine Exerts Synergistic Cytotoxic Effects Against FLT3/ITD Mutated Acute Myeloid Leukemia Cells

Edwin Stage, MS, Magdalena Czader, MD PhD, Heather O'Leary, PhD, H. Scott Boswell, MD, Larry D. Cripe, MD, Hamid Sayar, MD, Cedric Dos Santos, PhD, Mark J. Levis, MD PhD, Heiko Konig, MDPhD
Journal: Blood
Blood (2015) 126 (23): 4928.
https://doi.org/10.1182/blood.V126.23.4928.4928
Published: 2015